Gene therapy is revolutionizing the treatment landscape for neovascular age related macular degeneration (nAMD), an affliction that significantly impacts
Category: Ophthalmology
Biogen’s Strategic Move: Acquiring Apellis Pharmaceuticals for $5.6 Billion
Biogen has made a significant strategic leap by announcing its acquisition of Apellis Pharmaceuticals for approximately $5.6 billion. This deal not only
The Evolution and Impact of Fundus Autofluorescence Imaging
Fundus autofluorescence (FAF) imaging has emerged as a crucial non invasive technique in ophthalmology, allowing for detailed visualization of the retina
Advances in Autofluorescence Imaging for Retinal Diseases
Autofluorescence imaging, particularly through spectral domain optical coherence tomography (SD OCT), has revolutionized our understanding of retinal
Advancements of Virtual Reality in Eye Care
The integration of virtual reality (VR) into eye care is not just a futuristic notion; it is becoming a functional reality. Over the past two years, these